TRAX
First Tracks Biotherapeutics, Inc.Company Information
- Company Name
- First Tracks Biotherapeutics, Inc.
- CIK
- CIK0002091349
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- TRAX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- TRAX
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-09-02
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 4,744,840
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 32,733,134
- Shares outstanding
- 35,003,000
- Ownership
- 93.52%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- -12.29%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|
Assets | ||||||||
| Cash And Cash Equivalents At Carrying Value | 168 | 248 | ||||||
Assets Current | ||||||||
| Assets Current | 178 | 289 | ||||||
| Available For Sale Securities Debt Securities Current | 0 | 38 | ||||||
| Prepaid Expense And Other Assets Current | 10 | 3 | ||||||
| Property Plant And Equipment Net | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 4 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | ||||||
| Assets | 183 | 291 | ||||||
Liabilities And Stockholders Equity | ||||||||
| Accounts Payable Current | 3 | 7 | ||||||
Liabilities Current | ||||||||
| Accrued Liabilities Current | 7 | 26 | ||||||
| Liabilities Current | 12 | 33 | ||||||
| Operating Lease Liability Current | 2 | 0 | ||||||
| Operating Lease Liability Noncurrent | 2 | 0 | ||||||
| Preferred Stock Value | 0 | - | ||||||
| Common Stock Value | 0 | - | ||||||
| Additional Paid In Capital Common Stock | 193 | - | ||||||
Stockholders Equity | ||||||||
| Stockholders Equity | 169 | 257 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -25 | - | ||||||
| Members Capital | 0 | 258 | ||||||
| Liabilities And Stockholders Equity | 183 | 291 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 10,000 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | - | ||||||
| Common Stock Shares Authorized | 500 | - | ||||||
| Common Stock Shares Issued | 35 | - | ||||||
| Shares Outstanding | 35 | - | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialFirst Tracks Biotherapeutics, Inc. (TRAX) — SEC Financial Statements & Analysis
First Tracks Biotherapeutics, Inc. (TRAX) is a pharmaceutical preparations company, incorporated in DE. First Tracks Biotherapeutics, Inc. trades on Nasdaq as: TRAX. First Tracks Biotherapeutics, Inc. (TRAX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, First Tracks Biotherapeutics, Inc. carries a market cap of $704.26M, a P/B ratio of 4.17x, and an enterprise value of $536.24M. On the balance sheet, it maintains a current ratio of 14.28x, a quick ratio of 13.50x, working capital of $165.30M, a debt-to-equity ratio of 0.07x, a debt ratio of 0.07, and net debt of $-168.02M. Figures sourced from SEC EDGAR.
- Market Cap
- $704.26M
- P/B TTM
- 4.17x
- Debt To Equity
- 0.07x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is First Tracks Biotherapeutics, Inc. in?
First Tracks Biotherapeutics, Inc. (TRAX) operates in the Pharmaceutical Preparations industry.
What exchange does TRAX trade on?
First Tracks Biotherapeutics, Inc. (TRAX) trades on the Nasdaq.
Where is First Tracks Biotherapeutics, Inc. incorporated?
First Tracks Biotherapeutics, Inc. is incorporated in DE.
When was First Tracks Biotherapeutics, Inc. (TRAX)'s most recent SEC filing?
First Tracks Biotherapeutics, Inc. (TRAX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is TRAX's market cap?
First Tracks Biotherapeutics, Inc. (TRAX) has a market capitalization of $704.26M as of 2026-06-30.